Ge Lab
Biopharmaceutical Discovery
News Highlights
Turning therapeutic antibodies inside-out to fight cancer
Taking inspiration from camels and llamas, a UCR team flipped the active site of human antibodies to target tumor-promoting matrix metalloproteinases.
Camels and Llamas Provide Inspiration in the Fight Against Cancer
With their expressive faces and unusually shaped bodies, mammals within the camelid family—including camels, llamas, alpacas, vicuñas, and guanacos—are not the first groups of animals that typically come to mind when people think about cancer research.
Releviate Therapeutics Inks Exclusive License for Human Monoclonal Antibodies for Chronic Pain Indications
Therapies Based on Extensive Neuropathic Pain Research Conducted at UC Riverside and Duke University Target Chronic Pain at Its Source: Matrix Metalloproteinases
Engineering a Biomedical Career
After a decade teaching chemical engineering, a new Institute of Molecular Medicine recruit decided to dedicated 100 percent of his effort to a new professional challenge – biomedical research.
Media Reports
09/2026, Antibody Treatment Reverses Diabetic Nerve Pain in Mice – The Scientist (link)
09/2026, Monoclonal Antibodies Targeting MMP-9 Alleviate Peripheral Neuropathy in Diabetic Mice – Genetic Engineering & Biotechnology News (GEN) (link)
09/2026, UTHealth Houston team reverses nerve pain in diabetic mice – AAAS EurekAlert (link), News Wise (link), Mirage News (link) UTHealth Houston News (link)
09/2026, Targeted antibody treatment reverses diabetic nerve damage in mouse models – Medical Xpress (link)
12/2025, UTHealth Houston cancer researchers awarded nearly $10M from CPRIT – UTHealth Houston News (link)
09/2025, UTHealth Houston researchers awarded $2M to uncover a nonaddictive diabetic neuropathic pain therapy as the opioid crisis still looms in the US – UTHealth Houston News (link)
02/2023, The Many Facets of Flow Cytometry – Genetic Engineering & Biotechnology News (GEN) (link)
12/2021, Engineering a Biomedical Career – 2021 IMMpact Report (link)
10/2020, Therapies Based on Extensive Neuropathic Pain Research Conducted at UC Riverside and Duke University Target Chronic Pain at Its Source: Matrix Metalloproteinases – Business Wire (link), BioSpace (link), News Break, UCR Office of Technology Partnerships (link), Duke Innovations (link), and American Academy of Pain Medicine (AAPM) (link)
10/2017, 美国华裔教授新突破：独创方法 抑制癌细胞扩散 – 美国《世界日报》World Journal (link)
12/2016, Turning therapeutic antibodies inside-out to fight cancer – AAAS Eurekalert (link), Medical News Today (link), Medical Xpress (link), Bioengineering.org (link), Bioon, Business Standard, Drug Discovery and Development, Fierce Biotech, Health Canal, MedIndia, NEWS.am, Technology.org, Today Topics, and UCR Today
12/2016, Camels and Llamas Provide Inspiration in the Fight Against Cancer – Genetic Engineering & Biotechnology News (GEN) (link)